| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Biochemistry |
Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, 205 route de Narbonne, 31077 Toulouse cedex, France1
Author for correspondence: A. Quémard. Tel: +33 5 61 17 55 76. Fax: +33 5 61 17 59 94. e-mail: annaik{at}ipbs.fr
Most drug-resistant clinical isolates of the tubercle bacillus are resistant to isoniazid, a first-line antituberculous drug. This antibiotic was shown to act on Mycobacterium tuberculosis by inhibiting a 2-trans-enoyl-acyl carrier protein reductase, called InhA. However, the exact role played by InhA in mycobacteria remained unclear. A mycobacterial enzyme fraction containing InhA was isolated. It displays a long-chain fatty acid elongation activity with the characteristic properties described for the FAS-II (fatty acid synthetase II) system. Inhibition of this activity by InhA inhibitors, namely isoniazid, hexadecynoyl-CoA or octadecynoyl-CoA, showed that InhA belongs to the FAS-II system. Moreover, the InhA inhibitors also blocked the biosynthesis of mycolic acids, which are major lipids of the mycobacterial envelope. The data strongly suggest that isoniazid acts on the mycobacterial cell wall by preventing the FAS-II system from producing long-chain fatty acid precursors for mycolic acid biosynthesis.
Keywords: InhA, fatty acid synthetase II, mycolic acid biosynthesis, isoniazid target, Mycobacterium
Abbreviations: ACP, acyl carrier protein; FAS, fatty acid synthetase; FES, fatty acid elongation system; INH, isoniazid (isonicotinic acid hydrazide); NE, 2-(2,3-naphthalimino)ethyl; NE-OTf, 2-(2,3-naphthalimino)ethyl trifluoromethanesulphonate; pCMS, p-chloromercuriphenylsulphonic acid
This article has been cited by other articles:
|
|
 |
|
  A. Gurvitz, J. K. Hiltunen, and A. J. Kastaniotis Function of Heterologous Mycobacterium tuberculosis InhA, a Type 2 Fatty Acid Synthase Enzyme Involved in Extending C20 Fatty Acids to C60-to-C90 Mycolic Acids, during De Novo Lipoic Acid Synthesis in Saccharomyces cerevisiae Appl. Envir. Microbiol., August 15, 2008; 74(16): 5078 - 5085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Kruh, R. Rawat, B. P. Ruzsicska, and P. J. Tonge Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis Protein Sci., August 1, 2007; 16(8): 1617 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Ngo, O. Zimhony, W. J. Chung, H. Sayahi, W. R. Jacobs Jr., and J. T. Welch Inhibition of Isolated Mycobacterium tuberculosis Fatty Acid Synthase I by Pyrazinamide Analogs Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2430 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, J. Yue, Y.-p. Yang, H.-m. Zhang, J.-q. Lei, R.-l. Jin, X.-l. Zhang, and H.-h. Wang Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China J. Clin. Microbiol., November 1, 2005; 43(11): 5477 - 5482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Portevin, C. de Sousa-D'Auria, H. Montrozier, C. Houssin, A. Stella, M.-A. Laneelle, F. Bardou, C. Guilhot, and M. Daffe The Acyl-AMP Ligase FadD32 and AccD4-containing Acyl-CoA Carboxylase Are Required for the Synthesis of Mycolic Acids and Essential for Mycobacterial Growth: IDENTIFICATION OF THE CARBOXYLATION PRODUCT AND DETERMINATION OF THE ACYL-CoA CARBOXYLASE COMPONENTS J. Biol. Chem., March 11, 2005; 280(10): 8862 - 8874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takayama, C. Wang, and G. S. Besra Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis Clin. Microbiol. Rev., January 1, 2005; 18(1): 81 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ducasse-Cabanot, M. Cohen-Gonsaud, H. Marrakchi, M. Nguyen, D. Zerbib, J. Bernadou, M. Daffe, G. Labesse, and A. Quemard In Vitro Inhibition of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid Antimicrob. Agents Chemother., January 1, 2004; 48(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rawat, A. Whitty, and P. J. Tonge The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance PNAS, November 25, 2003; 100(24): 13881 - 13886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. van Doorn, E. C. J. Claas, K. E. Templeton, A. G. M. van der Zanden, A. te Koppele Vije, M. D. de Jong, J. Dankert, and E. J. Kuijper Detection of a Point Mutation Associated with High-Level Isoniazid Resistance in Mycobacterium tuberculosis by Using Real-Time PCR Technology with 3'-Minor Groove Binder-DNA Probes J. Clin. Microbiol., October 1, 2003; 41(10): 4630 - 4635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lamichhane, M. Zignol, N. J. Blades, D. E. Geiman, A. Dougherty, J. Grosset, K. W. Broman, and W. R. Bishai A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: Application to Mycobacterium tuberculosis PNAS, June 10, 2003; 100(12): 7213 - 7218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kremer, L. G. Dover, H. R. Morbidoni, C. Vilcheze, W. N. Maughan, A. Baulard, S.-C. Tu, N. Honore, V. Deretic, J. C. Sacchettini, et al. Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria J. Biol. Chem., May 30, 2003; 278(23): 20547 - 20554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Ramaswamy, R. Reich, S.-J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1241 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dinadayala, F. Laval, C. Raynaud, A. Lemassu, M.-A. Laneelle, G. Laneelle, and M. Daffe Tracking the Putative Biosynthetic Precursors of Oxygenated Mycolates of Mycobacterium tuberculosis. STRUCTURAL ANALYSIS OF FATTY ACIDS OF A MUTANT STRAIN DEVOID OF METHOXY- AND KETOMYCOLATES J. Biol. Chem., February 21, 2003; 278(9): 7310 - 7319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nguyen, A. Quemard, S. Broussy, J. Bernadou, and B. Meunier Mn(III) Pyrophosphate as an Efficient Tool for Studying the Mode of Action of Isoniazid on the InhA Protein of Mycobacterium tuberculosis Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2137 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Marrakchi, S. Ducasse, G. Labesse, H. Montrozier, E. Margeat, L. Emorine, X. Charpentier, M. Daffe, and A. Quemard MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II Microbiology, April 1, 2002; 148(4): 951 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vilchèze, H. R. Morbidoni, T. R. Weisbrod, H. Iwamoto, M. Kuo, J. C. Sacchettini, and W. R. Jacobs Jr. Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis J. Bacteriol., July 15, 2000; 182(14): 4059 - 4067. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
